Research investigates how glycemia influences islet rhythmicity in mice, revealing key cell interactions.
Blood glucose homeostasis relies on coordinated rhythmic activity across pancreatic islets. Glucose triggers islet rhythmicity, but population-level dynamics in pancreases in vivo remain unclear. Using simultaneous multi-islet Ca²⁺ imaging in mice and tissue, we systematically studied how glycemia fluctuations and intra-islet paracrine signaling collectively shape the islet rhythmicity. In this study, we report that a transition from hyperglycemia to euglycemia drove a coordinated shift from slow to fast islet Ca²⁺ oscillations (HESF) in vivo. HESF was conserved in pancreatic tissue slices but not in dispersed single β cells in vitro, linking the transition to paracrine signaling. Mechanistically, HESF arose from α-cell activation, which is inhibited by δ cells during hyperglycemia. In diabetic mice with unstable glycemia, islets lost HESF both in vivo and in vitro. Semaglutide restored HESF while stabilizing glycemia. These findings reveal how δ and α cells encode the glycemic state into islet rhythmicity to support stable blood glucose. A record of this paper's transparent peer review process is included in the supplemental information.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: